Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

721 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of polymorphic variation at 7p15.3, 3p22.1 and 2p23.3 loci on risk of multiple myeloma.
Martino A, Campa D, Jamroziak K, Reis RM, Sainz J, Buda G, García-Sanz R, Lesueur F, Marques H, Moreno V, Jurado M, Ríos R, Szemraj-Rogucka Z, Szemraj J, Tjønneland A, Overvad K, Vangsted AJ, Vogel U, Mikala G, Kádár K, Szombath G, Varkonyi J, Orciuolo E, Dumontet C, Gemignani F, Rossi AM, Landi S, Petrini M, Houlston RS, Hemminki K, Canzian F. Martino A, et al. Among authors: rossi am. Br J Haematol. 2012 Sep;158(6):805-9. doi: 10.1111/j.1365-2141.2012.09244.x. Epub 2012 Jul 24. Br J Haematol. 2012. PMID: 22823248 Free article. No abstract available.
Comprehensive investigation of genetic variation in the 8q24 region and multiple myeloma risk in the IMMEnSE consortium.
Campa D, Martino A, Sainz J, Buda G, Jamroziak K, Weinhold N, Vieira Reis RM, García-Sanz R, Jurado M, Ríos R, Szemraj-Rogucka Z, Marques H, Lesueur F, Bugert P, Moreno V, Szemraj J, Orciuolo E, Gemignani F, Rossi AM, Dumontet C, Petrini M, Goldschmidt H, Landi S, Canzian F. Campa D, et al. Among authors: rossi am. Br J Haematol. 2012 May;157(3):331-8. doi: 10.1111/j.1365-2141.2012.09047.x. Epub 2012 Feb 13. Br J Haematol. 2012. PMID: 22590720 Free article.
Risk of multiple myeloma is associated with polymorphisms within telomerase genes and telomere length.
Campa D, Martino A, Varkonyi J, Lesueur F, Jamroziak K, Landi S, Jurczyszyn A, Marques H, Andersen V, Jurado M, Brenner H, Petrini M, Vogel U, García-Sanz R, Buda G, Gemignani F, Ríos R, Vangsted AJ, Dumontet C, Martínez-López J, Moreno MJ, Stępień A, Wątek M, Moreno V, Dieffenbach AK, Rossi AM, Butterbach K, Jacobsen SE, Goldschmidt H, Sainz J, Hillengass J, Orciuolo E, Dudziński M, Weinhold N, Reis RM, Canzian F. Campa D, et al. Among authors: rossi am. Int J Cancer. 2015 Mar 1;136(5):E351-8. doi: 10.1002/ijc.29101. Epub 2014 Aug 6. Int J Cancer. 2015. PMID: 25066524
MDR1 polymorphism influences the outcome of multiple myeloma patients.
Buda G, Maggini V, Galimberti S, Martino A, Giuliani N, Morabito F, Genestreti G, Iacopino P, Rizzoli V, Barale R, Rossi AM, Petrini M. Buda G, et al. Among authors: rossi am. Br J Haematol. 2007 Jun;137(5):454-6. doi: 10.1111/j.1365-2141.2007.06605.x. Br J Haematol. 2007. PMID: 17488488 Free article.
Genetics and molecular epidemiology of multiple myeloma: the rationale for the IMMEnSE consortium (review).
Martino A, Sainz J, Buda G, Jamroziak K, Reis RM, García-Sanz R, Jurado M, Ríos R, Szemraj-Rogucka Z, Marques H, Lesueur F, Moreno V, Orciuolo E, Gemignani F, Landi S, Rossi AM, Dumontet C, Petrini M, Campa D, Canzian F. Martino A, et al. Among authors: rossi am. Int J Oncol. 2012 Mar;40(3):625-38. doi: 10.3892/ijo.2011.1284. Epub 2011 Dec 6. Int J Oncol. 2012. PMID: 22159523 Free article. Review.
Genetic variants and multiple myeloma risk: IMMEnSE validation of the best reported associations--an extensive replication of the associations from the candidate gene era.
Martino A, Campa D, Jurczyszyn A, Martínez-López J, Moreno MJ, Varkonyi J, Dumontet C, García-Sanz R, Gemignani F, Jamroziak K, Stępieł A, Jacobsen SE, Andersen V, Jurado M, Landi S, Rossi AM, Lesueur F, Marques H, Dudziński M, Wątek M, Moreno V, Orciuolo E, Petrini M, Reis RM, Ríos R, Sainz J, Vogel U, Buda G, Vangsted AJ, Canzian F. Martino A, et al. Among authors: rossi am. Cancer Epidemiol Biomarkers Prev. 2014 Apr;23(4):670-4. doi: 10.1158/1055-9965.EPI-13-1115. Epub 2014 Feb 12. Cancer Epidemiol Biomarkers Prev. 2014. PMID: 24521996
Type 2 diabetes-related variants influence the risk of developing multiple myeloma: results from the IMMEnSE consortium.
Ríos R, Lupiañez CB, Campa D, Martino A, Martínez-López J, Martínez-Bueno M, Varkonyi J, García-Sanz R, Jamroziak K, Dumontet C, Cayuela AJ, Wętek M, Landi S, Rossi AM, Lesueur F, Reis RM, Moreno V, Marques H, Jurczyszyn A, Andersen V, Vogel U, Buda G, Orciuolo E, Jacobsen SE, Petrini M, Vangsted AJ, Gemignani F, Canzian F, Jurado M, Sainz J. Ríos R, et al. Among authors: rossi am. Endocr Relat Cancer. 2015 Aug;22(4):545-59. doi: 10.1530/ERC-15-0029. Epub 2015 Jun 22. Endocr Relat Cancer. 2015. PMID: 26099684
Unusual association of endometrial cancer and multiple myeloma.
Buda G, Orciuolo E, Galimberti S, Petrini M, Maggini V, Barale R, Rossi AM. Buda G, et al. Among authors: rossi am. Gynecol Oncol. 2008 Aug;110(2):265-6; author reply 266. doi: 10.1016/j.ygyno.2007.08.065. Epub 2007 Oct 24. Gynecol Oncol. 2008. PMID: 17961643 No abstract available.
MDR1 diplotypes as prognostic markers in multiple myeloma.
Maggini V, Buda G, Martino A, Presciuttini S, Galimberti S, Orciuolo E, Barale R, Petrini M, Rossi AM. Maggini V, et al. Among authors: rossi am. Pharmacogenet Genomics. 2008 May;18(5):383-9. doi: 10.1097/FPC.0b013e3282f82297. Pharmacogenet Genomics. 2008. PMID: 18408561
721 results